1. Bevacizumab in ovarian cancer: Focus on clinical data and future perspectives. (January 2016) Authors: Colombo, Nicoletta; Conte, Pier Franco; Pignata, Sandro; Raspagliesi, Francesco; Scambia, Giovanni Journal: Critical reviews in oncology/hematology Issue: Volume 97(2016) Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. Issue 10 (3rd October 2018) Authors: Omarini, Claudia; Bettelli, Stefania; Caprera, Cecilia; Manfredini, Samantha; Caggia, Federica; Guaitoli, Giorgia; Moscetti, Luca; Toss, Angela; Cortesi, Laura; Kaleci, Shaniko; Maiorana, Antonino; Cascinu, Stefano; Conte, Pier Franco; Piacentini, Federico Journal: Cancer biology & therapy Issue: Volume 19:Issue 10(2018) Page Start: 879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum to "Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?" [Crit. Rev. Oncol. Hematol. 138 (June) (2019), 87–103]. (August 2019) Authors: Frega, Stefano; Dal Maso, Alessandro; Ferro, Alessandra; Bonanno, Laura; Conte, Pier Franco; Pasello, Giulia Journal: Critical reviews in oncology/hematology Issue: Volume 140(2019) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study. (23rd August 2021) Authors: Lorenzi, Martina; Ferro, Alessandra; Cecere, Fabiana; Scattolin, Daniela; Del Conte, Alessandro; Follador, Alessandro; Pilotto, Sara; Polo, Valentina; Santarpia, Mariacarmela; Chiari, Rita; Pavan, Alberto; Dal Maso, Alessandro; Da Ros, Valentina; Targato, Giada; Vari, Sabrina; Indraccolo, Stefano... Journal: Oncologist Issue: Volume 27:Number 2(2022) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis. (March 2020) Authors: Schettini, Francesco; Pascual, Tomás; Conte, Benedetta; Chic, Nuria; Brasó-Maristany, Fara; Galván, Patricia; Martínez, Olga; Adamo, Barbara; Vidal, Maria; Muñoz, Montserrat; Fernández-Martinez, Aranzazu; Rognoni, Carla; Griguolo, Gaia; Guarneri, Valentina; Conte, Pier Franco; Locci, Mariavittori... Journal: Cancer treatment reviews Issue: Volume 84(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus. (24th July 2018) Authors: Omarini, Claudia; Filieri, Maria Elisabetta; Bettelli, Stefania; Manfredini, Samantha; Kaleci, Shaniko; Caprera, Cecilia; Nasso, Cecilia; Barbolini, Monica; Guaitoli, Giorgia; Moscetti, Luca; Maiorana, Antonino; Conte, Pier Franco; Cascinu, Stefano; Piacentini, Federico Other Names: Buonaguro Franco M. Academic Editor. Journal: BioMed research international Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Trabectedin plus Pegylated Liposomal Doxorubicin: Retrospective Analysis in Heavily Pretreated Platinum-sensitive Ovarian Cancer. Issue 5 (September 2015) Authors: Nicoletto, Maria Ornella; Baldoni, Alessandra; Casarin, Alessandra; Randon, Giovanni; Nardin, Margherita; Baretta, Zora; Lardelli, Pilar; Nieto, Antonio; Alfaro, Vicente; Rigamonti, Claudia; Conte, Pier Franco Journal: Tumori Issue: Volume 101:Issue 5(2015) Page Start: 506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years. Issue 2 (21st September 2012) Authors: Cortesi, Laura; Marcheselli, Luigi; Guarneri, Valentina; Cirilli, Claudia; Braghiroli, Barbara; Toss, Angela; Sant, Milena; Ficarra, Guido; Conte, Pier Franco; Federico, Massimo Journal: International journal of cancer Issue: Volume 132:Issue 2(2013:Jan. 15) Page Start: E58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Weekly Low-Dose Paclitaxel as Maintenance Treatment in Patients With Advanced Ovarian Cancer Who Had Microscopic Residual Disease at Second-Look Surgery After 6 Cycles of Paclitaxel/Platinum-Based Chemotherapy: Results of an Open Noncomparative Phase 2 Multicenter Italian Study (After-6 Protocol 2). Issue 4 (1st April 2009) Authors: Gadducci, Angiolo; Katsaros, Dionyssios; Zola, Paolo; Scambia, Giovanni; Ballardini, Michela; Pasquini, Enzo; Fertonani, Carlo; Maggi, Lorenzo; Pecorelli, Sergio; Conte, Pier Franco Journal: International journal of gynecological cancer Issue: Volume 19:Issue 4(2009) Page Start: 615-619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗